Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) — The “Asia-Pacific Cell and Gene Therapy Biomanufacturing Market – Analysis and Forecast, 2022-2031” report has been added to ResearchAndMarkets.com’s offering.
The global healthcare sector observes a momentous shift with the new research publication unveiling comprehensive insights into the Asia-Pacific Cell and Gene Therapy Biomanufacturing Market. This pivotal analysis anticipates a soaring Compound Annual Growth Rate (CAGR) of 17.88% from 2022 to 2031, marking a prolific increase from $1.96 billion to a staggering $8.60 billion.
Impetus for the Market Expansion
Factors propelling the market growth are cited to be the surge in authorized treatments and the burgeoning need for advanced biomanufacturing infrastructures capable of catering to an expanding array of target indications for cell and gene therapies.
Significant investments by governments, pharmaceutical giants, and academic institutions in the APAC region are setting the stage for novel breakthroughs in medical treatments, thereby fuelling the demand for sophisticated biomanufacturing solutions.
The report meticulously segments the market to furnish a granular analysis of the industry dynamics. The segmentation delves into:
- Product Type, including Consumables, Equipment, and Software Solutions
- End Users such as Life Science Companies, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), and Cell Banks
- Geographical distribution spanning China, Japan, India, South Korea, Australia/New Zealand, and the broader Rest-of-Asia-Pacific region
Strategic Analysis for Market Participants
For entities participating in the APAC market, the report presents an invaluable resource for formulating workflow and innovation strategies, as well as for guiding growth and marketing efforts to capture the emergent opportunities in cell and gene therapy biomanufacturing.
Industry Drivers and Challenges
Among the primary drivers underpinning the market’s promising outlook are:
- The ongoing expansion in target indications requiring large-scale biomanufacturing capabilities.
- The influx of new market entrants necessitating a robust infrastructure for biomanufacturing.
- A robust clinical pipeline further demanding enhanced biomanufacturing infrastructure.
Conversely, the market must navigate through challenges such as the high initial setup costs associated with biomanufacturing facilities.
Competitive Landscape and Key Market Innovators
Comprehensive profiling of leading market contributors reveals the competitive strategic landscapes. This analysis highlights the key players’ innovative product launches, acquisitions, expansions, and strategic collaborations, offering a competitive benchmarking that elucidates the position of each market player.
Potential for Transformational Impact
Encompassing a period of rapid industrial change and projected growth, the findings within the report underscore the Asia-Pacific region’s critical role in the global biomanufacturing landscape.
With the market poised for exponential growth, stakeholders across the healthcare and biotechnology sectors are set to witness an era marked by groundbreaking advancements and strategic market shifts in cell and gene therapy biomanufacturing.
|No. of Pages
|2022 – 2031
|Estimated Market Value (USD) in 2022
|Forecasted Market Value (USD) by 2031
|Compound Annual Growth Rate
Key Market Segmentation:
Segmentation by Product Type
- Software Solutions
Segmentation by End User
- Life Science Companies
- Contract Research Organizations (CROs)
- Contract Manufacturing Organizations (CMOs)
- Cell Banks
Segmentation by Country
- South Korea
- Australia/New Zealand
For more information about this report visit https://www.researchandmarkets.com/r/oyqvry
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Asia-Pacific Cell and Gene Therapy Biomanufacturing Market